Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

2(33%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

N/ANon-phased studies

3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(1)

Other(3)

Detailed Status

unknown3

Recruiting2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed117%

unknown350%

recruiting233%

Recent Activity

2 active trials

Showing 5 of 6

recruiting

Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM)

NCT02758977

unknownnot_applicable

RALPPS Venus ALPPS for Hepatocellular Carcinoma

NCT02299843

View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials

NCT07142213

Effect and Mechanism of ALPPS Operation on Liver Regeneration

Recruiting

NCT06050200Not Applicable

TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery

Recruiting

NCT02164292

ALPPS: Safety, Feasibility and Efficacy at a Single Center

Completed

NCT02758977Not Applicable

Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM)

Unknown

NCT02299843Not Applicable

RALPPS Venus ALPPS for Hepatocellular Carcinoma

Unknown

NCT01924741

Registry of Major Liver Resections Including ALPPS and Other Liver Resections in Two Stages

Unknown

All 6 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 6